|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Allogene Therapeutics, Inc. (ALLO) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
140,280,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Allogene Therapeutics is a clinical stage immuno-oncology company focused on the development of genetically engineered allogeneic T cell therapies for the treatment of cancer. Co.'s key product candidates, ALLO-501 and ALLO-501A, are engineered allogeneic Chimeric antigen receptor (CAR) T cell therapies that target CD19, a protein expressed on the cell surface of B cells and a validated target for B cell driven hematological malignancies. Co. is also developing engineered allogeneic CAR T cell product candidates for multiple myeloma, clear cell renal cell carcinoma, and other blood cancers and solid tumors.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
190 |
190 |
190 |
| Total Buy Value |
$0 |
$683 |
$683 |
$683 |
| Total People Bought |
0 |
1 |
1 |
1 |
| Total Buy Transactions |
0 |
1 |
1 |
1 |
| Total Shares Sold |
0 |
18,640 |
28,640 |
82,742 |
| Total Sell Value |
$0 |
$50,317 |
$93,172 |
$700,150 |
| Total People Sold |
0 |
1 |
2 |
5 |
| Total Sell Transactions |
0 |
1 |
2 |
12 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Coulter James G |
10% Owner |
– – • |
2020-06-15 |
4 |
S |
$42.14 |
$5,442,885 |
I/I |
(129,154) |
20,597,932 |
|
- |
|
| Witte Owen N. |
|
– • – |
2020-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
9,969 |
246,151 |
|
- |
|
| Humer Franz B |
|
– • – |
2020-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
9,969 |
131,216 |
|
- |
|
| Kazam Joshoa A |
|
– • – |
2020-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
9,969 |
1,033,305 |
|
- |
|
| Coulter James G |
10% Owner |
– – • |
2020-06-04 |
4 |
S |
$47.11 |
$85,638 |
I/I |
(1,818) |
20,727,086 |
|
- |
|
| Belldegrun Arie |
|
– • – |
2020-06-04 |
4 |
B |
$47.00 |
$6,879,954 |
I/I |
146,382 |
1,798,163 |
0.01 |
- |
|
| Coulter James G |
10% Owner |
– – • |
2020-06-03 |
4 |
S |
$47.13 |
$23,102,514 |
I/I |
(487,402) |
20,728,904 |
|
- |
|
| Chang David D |
President and CEO |
• • – |
2020-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
9,187 |
2,224,101 |
|
- |
|
| Chang David D |
President and CEO |
• • – |
2020-04-24 |
4 |
A |
$0.00 |
$0 |
I/I |
9,198 |
1,201,108 |
|
- |
|
| Kazam Joshoa A |
|
– • – |
2020-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
8,039 |
1,023,336 |
|
- |
|
| Bhavnagri Veer |
General Counsel |
• – – |
2020-04-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
360,455 |
|
- |
|
| Chang David D |
President and CEO |
• • – |
2020-03-18 |
4 |
GA |
$0.00 |
$0 |
I/I |
856,044 |
650,266 |
|
- |
|
| Schmidt Eric Thomas |
Chief Financial Officer |
• – – |
2020-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
30,800 |
78,706 |
|
- |
|
| Moore Alison |
Chief Technical Officer |
• – – |
2020-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
30,800 |
93,821 |
|
- |
|
| Amado Rafael |
EVP of R&D and CMO |
• – – |
2020-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
30,800 |
135,962 |
|
- |
|
| Schmidt Eric Thomas |
Chief Financial Officer |
• – – |
2020-03-16 |
4 |
S |
$19.70 |
$107,508 |
D/D |
(5,450) |
47,906 |
|
- |
|
| Moore Alison |
Chief Technical Officer |
• – – |
2020-03-16 |
4 |
S |
$19.19 |
$71,980 |
D/D |
(3,750) |
63,021 |
|
- |
|
| Chang David D |
President and CEO |
• • – |
2020-03-16 |
4 |
S |
$19.24 |
$392,615 |
D/D |
(20,335) |
2,214,914 |
|
- |
|
| Chang David D |
President and CEO |
• • – |
2020-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
9,391 |
2,234,136 |
|
- |
|
| Chang David D |
President and CEO |
• • – |
2020-03-04 |
4 |
A |
$0.00 |
$0 |
I/I |
9,402 |
1,191,910 |
|
- |
|
| Kazam Joshoa A |
|
– • – |
2020-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
8,217 |
1,015,297 |
|
- |
|
| Schmidt Eric Thomas |
Chief Financial Officer |
• – – |
2020-02-20 |
4 |
D |
$25.30 |
$6,000,022 |
I/I |
(237,155) |
1,227,595 |
|
- |
|
| Chang David D |
President and CEO |
• • – |
2019-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
9,391 |
2,215,354 |
|
- |
|
| Chang David D |
President and CEO |
• • – |
2019-10-25 |
4 |
A |
$0.00 |
$0 |
I/I |
9,402 |
1,173,106 |
|
- |
|
| Kazam Joshoa A |
|
– • – |
2019-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
8,217 |
1,445,486 |
|
- |
|
103 Records found
|
|
Page 4 of 5 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
